CD47-SIRPα has been proposed as a regulator in the development of T cell-mediated autoimmune pathogenesis, including multiple sclerosis (MS), autoimmune hemolytic anemia (AIHA) and autoimmune diabetes [19,95]. Here, SIRPA is linked to autoimmune hemolytic anemia.